| Date | Ticker | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 16, 2026 | Abacus Global Management, Inc. | van Katwijk Cornelis Michiel | sell | 17,327 | $10.10 | $175K |
| Mar 16, 2026 | AKAMAI TECHNOLOGIES INC | Joseph Paul C EVP - Global Sales | sell | 2,967 | $105.89 | $314K |
| Mar 16, 2026 | AKAMAI TECHNOLOGIES INC | Joseph Paul C EVP - Global Sales | sell | 1,950 | $106.73 | $208K |
| Mar 16, 2026 | Abacus Global Management, Inc. | Gusky Adam Samuel | sell | 17,327 | $10.10 | $175K |
| Mar 16, 2026 | Abacus Global Management, Inc. | Schulte Mary Beth | sell | 20,792 | $10.10 | $210K |
| Mar 16, 2026 | Abacus Global Management, Inc. | Radka Karla | sell | 17,327 | $10.10 | $175K |
| Mar 16, 2026 | UNITED THERAPEUTICS Corp | Olian Judy D. | sell | 200 | $535.44 | $107K |
| Mar 16, 2026 | FHI👔 FEDERATED HERMES, INC. | DONAHUE THOMAS R VP, CFO & Treasurer | sell | 30,000 | $57.10 | $1.71M$1M+ |
| Mar 16, 2026 | FHI👔 FEDERATED HERMES, INC. | Uhlman Paul A Vice President | sell | 62,105 | $56.15 | $3.49M$1M+ |
| Mar 16, 2026 | FHI👔 FEDERATED HERMES, INC. | Uhlman Paul A Vice President | sell | 10,287 | $56.72 | $584K |
| Mar 16, 2026 | Nuvalent, Inc. | Pelish Henry E. Chief Scientific Officer | sell | 24,189 | $97.79 | $2.37M$1M+ |
| Mar 16, 2026 | Nuvalent, Inc. | Pelish Henry E. Chief Scientific Officer | sell | 1,703 | $99.71 | $170K |
| Mar 16, 2026 | UTHR👔 UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO | sell | 2,030 | $537.29 | $1.09M$1M+ |
| Mar 16, 2026 | UTHR👔 UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO | sell | 2,019 | $538.31 | $1.09M$1M+ |
| Mar 16, 2026 | UTHR👔 UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO | sell | 480 | $541.21 | $260K |
| Mar 16, 2026 | Nuvalent, Inc. | Pelish Henry E. Chief Scientific Officer | sell | 5,505 | $98.44 | $542K |
| Mar 16, 2026 | UTHR👔 UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO | sell | 944 | $535.43 | $505K |
| Mar 16, 2026 | UTHR👔 UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO | sell | 1,546 | $539.26 | $834K |
| Mar 16, 2026 | Nuvalent, Inc. | Pelish Henry E. Chief Scientific Officer | sell | 2,597 | $98.83 | $257K |
| Mar 16, 2026 | UTHR👔 UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO | sell | 1,536 | $536.32 | $824K |